Vaccines Market Trends 2020 Global Industry Analysis, Top Manufacturers, Technology, Share, Growth, Opportunities & Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Feb 04, 2021 (Market Insight Reports) —
Selbyville, Delaware, Global Vaccines Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2026. Vaccines Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Vaccines market and provides information regarding the revenue for the period 2020 to 2026.

The vaccines market is likely to register significant gains in coming years owing to the growing geriatric population, high risk of fatality among the pediatric population, the ongoing fight against the COVID-19 pandemic, development of new vaccines for meningococcal diseases, and various government-sponsored initiatives towards the consolidation of their respective healthcare infrastructure.

Request a sample Report of Vaccines Market at:

Vaccine is a type of medicine which essentially trains the body’s immune system to effectively fight a disease which it has not encountered before. It is known as a biological substance specifically designed for protecting humans from infections mainly caused by viruses and bacteria. Generally, vaccines are given in the form of injection, but at times some of them are given nasally or even orally.

Some of the prominent players operating in the vaccines market include Abbott, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Merck & Co. Inc., Pfizer, and Sanofi. These market players are adopting various inorganic growth strategies to gain market share and sustainable competitive advantage.

The vaccines market is bifurcated in terms of age group, disease, technology, and regional landscape.

Based on age group, the vaccines market is categorized into adult and pediatric. Among these, adult segment will witness more than 16.7% CAGR through the projected time period. Factors such as high risk of mortality due to underlying comorbidities and age, increasing geriatric population, and high risk of acquiring COVID-19 infection will further drive the overall segment growth.

As in children, vaccines are equally important for adults to protect them from various diseases that might have a serious or deadly consequences if left untreated. A common instance is the Flu shots that are recommended for elderly population during flu season. It is extremely essential for those who are suffering from chronic illnesses and those above the age of 65.

From a regional frame of reference, Asia-Pacific vaccines market is likely to witness tremendous gains owing to presence of large geriatric population, increasing government initiatives for the development of numerous vaccination programs, and rising awareness.

With respect to disease, the vaccines market is classified into rotavirus, polio, meningococcal disease, human papilloma virus, influenza, dengue, DTP, pneumococcal disease, hepatitis, cancer, and others. Among these, meningococcal disease segment will witness substantial growth over the coming years. Factors such as development of new vaccines for meningococcal diseases, high risk of fatality in pediatric population, and regulatory approvals will drive the segmental growth.

In terms of technology, the overall vaccines market is segmented into toxoid, recombinant, inactivated, live, conjugate, and others. Among these, inactivated technology segment is likely to grow at a CAGR of more than 22% over the forecast timeframe. Increasing focus of research institutes and pharmaceutical companies towards the development of an effective COVID-19 vaccine based on inactivated virus technology will contribute towards industry growth.

Inactivated vaccines are a form of vaccine, in which the virus is inactivated during the vaccine making process. Various inactivated vaccines are available as whole-cell inactivated vaccines and utilized to protect against diseases like rabies, hepatitis A, polio, and flu.

For More Details on Vaccines Market Report at:

About Us:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]

Web site:



Is there a problem with this press release? Contact the source provider Comtex at [email protected]. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Next Post

Adobe: Holiday Online Shopping Topped $188.2B

Share Tweet Share Share Share Email The 2020 holiday season was rife with online shopping, which hit a record $188.2 billion, or two years’ worth of growth, according to an analysis from Adobe Digital Insights (ADI). That number represents a 32 percent increase over the same time the previous year, […] WordPress Theme: Seek by ThemeInWP